Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

VedaBio has entered into agreement with Mammoth Biosciences to enhance its CRISPR-based molecular detection platform for ...

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading the developmental race).

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $51.81, marking a -3.5% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.3% for the ...

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...

Scientists at the University of California, Davis, have developed wheat plants that stimulate production of its own fertilizer, which could bring environmental and cost-reduction benefits. A study was ...